EP2471547A4 - Apoptoseinduktor - Google Patents

Apoptoseinduktor

Info

Publication number
EP2471547A4
EP2471547A4 EP10812094.0A EP10812094A EP2471547A4 EP 2471547 A4 EP2471547 A4 EP 2471547A4 EP 10812094 A EP10812094 A EP 10812094A EP 2471547 A4 EP2471547 A4 EP 2471547A4
Authority
EP
European Patent Office
Prior art keywords
inducer
apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10812094.0A
Other languages
English (en)
French (fr)
Other versions
EP2471547A1 (de
Inventor
Chiaki Hidai
Hisataka Kitano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon University
Original Assignee
Nihon University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon University filed Critical Nihon University
Publication of EP2471547A1 publication Critical patent/EP2471547A1/de
Publication of EP2471547A4 publication Critical patent/EP2471547A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP10812094.0A 2009-08-25 2010-08-25 Apoptoseinduktor Withdrawn EP2471547A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009194747 2009-08-25
PCT/JP2010/064857 WO2011025050A1 (ja) 2009-08-25 2010-08-25 アポトーシス誘導剤

Publications (2)

Publication Number Publication Date
EP2471547A1 EP2471547A1 (de) 2012-07-04
EP2471547A4 true EP2471547A4 (de) 2013-10-23

Family

ID=43628136

Family Applications (1)

Application Number Title Priority Date Filing Date
EP10812094.0A Withdrawn EP2471547A4 (de) 2009-08-25 2010-08-25 Apoptoseinduktor

Country Status (4)

Country Link
US (1) US20120245099A1 (de)
EP (1) EP2471547A4 (de)
JP (1) JP5786266B2 (de)
WO (1) WO2011025050A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140378659A1 (en) * 2012-02-10 2014-12-25 National Cerebral And Cardiovascular Center Oxidized ldl inhibitor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003046139A2 (en) * 2001-11-26 2003-06-05 Exelixis, Inc. CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
WO2008048773A2 (en) * 2006-10-13 2008-04-24 The Regents Of The University Of California Models of atherosclerosis, hyperlipidemia, lipoprotein oxidation and blood vessel inflammation and methods for making and using them
EP2085473A1 (de) * 2006-10-10 2009-08-05 Nihon University Hilfsreagens für gentransfer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874562A (en) * 1995-06-07 1999-02-23 Progenitor, Inc. Nucleic acid encoding developmentally-regulated endothelial cell locus-1
US20030104622A1 (en) * 1999-09-01 2003-06-05 Robbins Paul D. Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
US7517655B2 (en) * 2003-06-30 2009-04-14 Nihon University Protein capable of deposition onto extracellular matrix
JP5254635B2 (ja) 2008-02-15 2013-08-07 キヤノン株式会社 通信装置およびその制御方法、プログラム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003046139A2 (en) * 2001-11-26 2003-06-05 Exelixis, Inc. CRBs AS MODIFIERS OF BRANCHING MORPHOGENESIS AND METHOD OF USE
EP2085473A1 (de) * 2006-10-10 2009-08-05 Nihon University Hilfsreagens für gentransfer
WO2008048773A2 (en) * 2006-10-13 2008-04-24 The Regents Of The University Of California Models of atherosclerosis, hyperlipidemia, lipoprotein oxidation and blood vessel inflammation and methods for making and using them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BORENSZTAJN KEREN S ET AL: "Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation.", EXPERIMENTAL CELL RESEARCH, vol. 313, no. 12, 15 July 2007 (2007-07-15), pages 2622 - 2633, XP002712320, ISSN: 0014-4827, DOI: 10.1016/j.yexcr.2007.04.014 *
LEIMEISTER CORNELIA ET AL: "Cloning and expression analysis of the mouse stroma marker Snep encoding a novel nidogen domain protein", DEVELOPMENTAL DYNAMICS, WILEY-LISS, INC., NEW YORK, NY, US, vol. 230, no. 2, 1 June 2004 (2004-06-01), pages 371 - 377, XP002415839, ISSN: 1058-8388, DOI: 10.1002/DVDY.20056 *
WANG Z ET AL: "Effect of the angiogenic factor Del-1 on endothelial cell apoptosis", JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, COLLEGE, CHICAGO, IL, US, vol. 201, no. 3, 1 September 2005 (2005-09-01), pages S104, XP027681716, ISSN: 1072-7515, [retrieved on 20050901] *

Also Published As

Publication number Publication date
WO2011025050A1 (ja) 2011-03-03
US20120245099A1 (en) 2012-09-27
EP2471547A1 (de) 2012-07-04
JPWO2011025050A1 (ja) 2013-01-31
JP5786266B2 (ja) 2015-09-30

Similar Documents

Publication Publication Date Title
EP2377028A4 (de) Änderung von befehlen
EP2427822A4 (de) Ausnahmemeldung
EP2434890A4 (de) Iap-hemmer
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
BRPI1011813A2 (pt) "inalador"
EP2324842A4 (de) Immunitätsinduzierer
PL2324831T3 (pl) Terapia pirfenidonem z wykluczeniem fluwoksaminy
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
EP2242362A4 (de) Iap-hemmer
BRPI1011587A2 (pt) compostos e composições terapèuticas
EP2724729A4 (de) Apoptoseauslöser
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
PL2435825T3 (pl) Sposoby leczenia chorób
IT1395915B1 (it) Potabilizzatore d'acqua
PL2493466T3 (pl) Nowe przeciwguzowe zastosowanie kabazytakselu
HUE040085T2 (hu) PDE7 inhibitorok alkalmazása mozgási rendellenességek kezelésére
DK2411009T3 (da) Terapeutiske anvendelser af quinazolindionderivater
DE112010004348A5 (de) Duschkopf
LT2506840T (lt) Hipoksija sukeliančio faktoriaus inhibitorių naudojimas
EP2421882A4 (de) Angiogenesehemmer
EP2465524A4 (de) Inhibitor für die autoantikörper-herstellung
EP2515659A4 (de) Herbizidzusammensetzung
SMT201600041B (it) Agenti terapeutici 713
EP2424875A4 (de) Reinigung von immunkonjugaten

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120316

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 43/00 20060101ALI20130906BHEP

Ipc: C07K 14/745 20060101ALI20130906BHEP

Ipc: A61P 35/00 20060101ALI20130906BHEP

Ipc: C07K 14/485 20060101ALI20130906BHEP

Ipc: A61K 38/00 20060101AFI20130906BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20130924

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20130917BHEP

Ipc: A61P 43/00 20060101ALI20130917BHEP

Ipc: C07K 14/485 20060101ALI20130917BHEP

Ipc: A61K 38/00 20060101AFI20130917BHEP

Ipc: C07K 14/745 20060101ALI20130917BHEP

17Q First examination report despatched

Effective date: 20160321

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160802